Songjian Lu

St. Jude Children's Research Hospital — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

25h-index2.5kcitations101works1.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Bioinformatics and Genomic Networks(21), Phagocytosis and Immune Regulation(18), Complexity and Algorithms in Graphs(15), Cancer-related molecular mechanisms research(14), Advanced Graph Theory Research(13)

Publications100 total

Clinical application of Azithromycin in treating pediatric Mycoplasma Pneumonia and its effects on platelet count, D-Dimer Levels, and Serum Inflammatory Factors
Pakistan Journal of Medical Sciences·2025Open Access
Retraction of Activation of Rac1 by Src-dependent phosphorylation of Dock180Y1811 mediates PDGFRα-stimulated glioma tumorigenesis in mice and humans
Journal of Clinical Investigation·2025Open Access
Tackling Critical Issues in scRNA-seq Data Normalization and Bulk RNA-seq Data Cell Type Deconvolution
Preprints.org·2025Open Access
Tackling Critical Issues in scRNA-seq Data Normalization and Bulk RNA-seq Data Cell Type Deconvolution
Preprints.org·2025Open Access
Transcriptome size matters for single-cell RNA-seq normalization and bulk deconvolution
Nature Communications·2025· 7 citedOpen Access
Data from Activation of the Receptor Tyrosine Kinase AXL Regulates the Immune Microenvironment in Glioblastoma
2023Open Access
Figure S2 from Activation of the Receptor Tyrosine Kinase AXL Regulates the Immune Microenvironment in Glioblastoma
2023Open Access
Data from Signal-Oriented Pathway Analyses Reveal a Signaling Complex as a Synthetic Lethal Target for p53 Mutations
2023Open Access
Supplementary figure legends from Activation of the Receptor Tyrosine Kinase AXL Regulates the Immune Microenvironment in Glioblastoma
2023Open Access
Figure S2 from Activation of the Receptor Tyrosine Kinase AXL Regulates the Immune Microenvironment in Glioblastoma
2023Open Access
Figure S6 from Activation of the Receptor Tyrosine Kinase AXL Regulates the Immune Microenvironment in Glioblastoma
2023Open Access
Figure S4 from Activation of the Receptor Tyrosine Kinase AXL Regulates the Immune Microenvironment in Glioblastoma
2023Open Access
Supplementary Figures, Results, and Methods from Signal-Oriented Pathway Analyses Reveal a Signaling Complex as a Synthetic Lethal Target for p53 Mutations
2023Open Access
Table S1 from Signal-Oriented Pathway Analyses Reveal a Signaling Complex as a Synthetic Lethal Target for p53 Mutations
2023Open Access
Data from Signal-Oriented Pathway Analyses Reveal a Signaling Complex as a Synthetic Lethal Target for p53 Mutations
2023Open Access
Figure S4 from Activation of the Receptor Tyrosine Kinase AXL Regulates the Immune Microenvironment in Glioblastoma
2023Open Access
Tabel S2 from Signal-Oriented Pathway Analyses Reveal a Signaling Complex as a Synthetic Lethal Target for p53 Mutations
2023Open Access
Table S4 from Signal-Oriented Pathway Analyses Reveal a Signaling Complex as a Synthetic Lethal Target for p53 Mutations
2023Open Access
Figure S5 from Activation of the Receptor Tyrosine Kinase AXL Regulates the Immune Microenvironment in Glioblastoma
2023Open Access
Tabel S2 from Signal-Oriented Pathway Analyses Reveal a Signaling Complex as a Synthetic Lethal Target for p53 Mutations
2023Open Access
page 1 of 5Next →

Frequent Co-authors

Xinghua Lu(24), Jianer Chen(16), Lifan Liang(8), Yang Liu(6), Bo Hu(6), Sing‐Hoi Sze(6), Ichiro Nakano(5), Shi‐Yuan Cheng(5), Chunhui Cai(5), Lujia Chen(5), Gregory F. Cooper(5), Vicky Chen(5), Fenghui Zhang(4), Kunju Zhu(4), Xiaojun Ma(4), Yang Liu(4), Tianzhi Huang(3), Angel A. Alvarez(3), Rajendra P. Pangeni(3), John A. Kessler(3)